"La Clinique Pasteur Lanroze est un établissement de santé pluridisciplinaire situé à Brest, en Bretagne. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Clinique Pasteur conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Pasteur" #1 sponsor was "Pfizer" with 4 trials, followed by "UNICANCER" with 4 trials sponsored, "Center Eugene Marquis" with 3 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored and "ARCAGY/ GINECO GROUP" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Pasteur" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Pasteur" are "Prostate Cancer" (3 trials), "Cancer of the Prostate" (2 trials), "Chemotherapy-induced Peripheral Neuropathy" (2 trials), "Colorectal Cancer" (2 trials) and "Oropharynx Cancer" (2 trials). Many other conditions were trialed in "Clinique Pasteur" in a lesser frequency.

Most popular intervention types in "Clinique Pasteur" are "Drug" (18 trials), "Other" (4 trials), "Radiation" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Avelumab" (3 trials), "Bevacizumab" (2 trials), "Calmangafodipir (5 µmol/kg)" (2 trials) and "Enzalutamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Pasteur" are 13 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Pasteur". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinique Pasteur, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Pasteur, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".